• Sulforaphane Mitigates PM2.5-Induced COPD via Nrf2 and EGFR

  2026-07-17

  This study demonstrates that sulforaphane attenuates PM2.5-induced chronic obstructive pulmonary disease by activating Nrf2 and inhibiting EGFR/PI3K/AKT signaling. The findings advance mechanistic understanding of phytotherapeutic intervention in environmentally induced COPD and highlight ROS quantification as a critical tool for elucidating redox-driven disease processes.

• GI 254023X: Precision ADAM10 Inhibitor Workflows & Optimizat

  2026-07-17

  GI 254023X, a highly selective ADAM10 inhibitor from APExBIO, empowers researchers to dissect Notch1 signaling, apoptosis, and vascular barrier integrity with nanomolar precision. Discover optimized protocols, real-world troubleshooting, and translational advantages that distinguish GI 254023X from broader-spectrum metalloprotease inhibitors.

• ML365 Inhibits Hippocampal NLRP3 Inflammasome to Ameliorate

  2026-07-16

  The referenced study demonstrates that ML365, a selective K2P channel inhibitor, effectively reduces postoperative cognitive dysfunction (POCD) in aged mice by suppressing NLRP3 inflammasome activation in the hippocampus. These findings clarify the mechanistic role of potassium channel modulation in neuroinflammation, offering a targeted approach for mitigating cognitive impairment after surgery.

• Lipo3K Transfection Reagent: High-Efficiency Gene Delivery R

  2026-07-16

  Lipo3K Transfection Reagent delivers exceptional nucleic acid transfection, even in notoriously difficult-to-transfect cells, with markedly reduced cytotoxicity. Its dual-component system and serum compatibility make it a superior platform for advanced gene expression and RNA interference research, setting new standards for reproducibility and efficiency.

• CHIR-99021: Strategic GSK-3 Inhibition for Translational Imp

  2026-07-15

  Explore how the selective GSK-3 inhibitor CHIR-99021 (CT99021) from APExBIO is redefining mechanistic and translational research, bridging stem cell biology with vascular disease modeling. This article blends mechanistic insight, protocol guidance, and a strategic outlook for researchers leveraging Wnt/β-catenin and TGF-β/Nodal pathways.

• BRD4770: Advanced G9a Histone Methyltransferase Inhibitor Wo

  2026-07-15

  BRD4770 empowers cancer biology research with precise, reproducible inhibition of G9a histone methyltransferase and downstream epigenetic modulation. Applied in senescence and proliferation assays, it enables robust interrogation of tumorigenic pathways while offering streamlined troubleshooting for experimental challenges.

• 5-EdU: Mechanistic Insight and Strategic Leverage in Transla

  2026-07-14

  This thought-leadership article bridges mechanistic insight and strategic guidance for translational researchers by spotlighting 5-Ethynyl-2'-deoxyuridine (5-EdU) as an advanced tool for cell proliferation studies. Building on recent glioblastoma research, it contextualizes 5-EdU’s unique advantages in experimental design, workflow efficiency, and translational impact, while offering practical protocol guidance and an evidence-driven outlook for next-generation assay development.

• G-1: Mechanistic Powerhouse for Translational GPR30 Research

  2026-07-14

  Explore how G-1, a selective GPR30 agonist, transforms mechanistic and translational research in cardiovascular, oncology, and immunological domains. Drawing on recent mechanistic studies and best-practice protocols, this article provides strategic guidance for researchers leveraging G-1 to dissect non-classical estrogen signaling, with a focus on validated workflows, competitive differentiation, and future directions.

• TG003 Cdc2-like Kinase Inhibitor: Reliable Splicing Modulati

  2026-07-13

  This article provides scenario-driven, evidence-based strategies for using TG003 Cdc2-like kinase (Clk) inhibitor (SKU B1431) to address core challenges in cell-based splicing, viability, and resistance assays. It details protocol optimization, data interpretation, and product selection, enabling researchers to leverage validated workflows for reproducible results.

• CFTRinh-172: Dissecting CFTR Inhibition for Advanced Epithel

  2026-07-13

  Explore the selective CFTR inhibitor CFTRinh-172 and its pivotal role in cystic fibrosis research. This article delivers a deep, evidence-driven analysis of its mechanism, specificity, and unique assay insights for epithelial models.

• 1-myristoylglycerophosphocholine: Applied Workflows in Smoot

  2026-07-12

  1-myristoylglycerophosphocholine (14:0 Lyso-PC) delivers precise control for dissecting lipid signaling in both smooth muscle contraction and fibrotic disease models. This article translates cutting-edge research into actionable protocols, troubleshooting insights, and advanced applications using APExBIO’s trusted reagent.

• Applied Workflows for (Z)-4-Hydroxytamoxifen in ER Modulatio

  2026-07-10

  (Z)-4-Hydroxytamoxifen offers superior estrogen receptor modulation and antiestrogenic activity, making it indispensable for advanced breast cancer and endocrine signaling research. This article details optimized protocols, troubleshooting guidance, and cross-study insights to maximize reproducibility and biological impact.

• CCCP and Mitochondrial Stress Testing: Assay Optimization an

  2026-07-09

  Explore how CCCP (carbonyl cyanide m-chlorophenyl hydrazine) enables advanced, reproducible mitochondrial stress assays, with deep technical insights for optimizing biomarker discovery in neurodegenerative research. Learn how this uncoupler transforms experimental design and interpretation.

• Idoxuridine in Antiviral Research: Protocols, Use-Cases, and

  2026-07-09

  Idoxuridine (5-iodo-2'-deoxyuridine) is a benchmark antiviral agent for dissecting viral DNA replication and evaluating DNA synthesis inhibition in research models. This guide highlights advanced workflows, real-world troubleshooting, and how APExBIO’s research-grade Idoxuridine enables reproducible, high-impact virology studies.

• Fluorescein TSA Fluorescence System Kit: Signal Amplificatio

  2026-07-08

  The Fluorescein TSA Fluorescence System Kit enables sensitive fluorescence detection of low-abundance biomolecules by HRP-catalyzed tyramide signal amplification. This kit, supplied by APExBIO, delivers robust, high-density signals in immunohistochemistry, immunocytochemistry, and in situ hybridization, with proven specificity and workflow flexibility.

451 records 11/31 page Previous Next First page 上5页 1112131415 下5页 Last page